BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16690446)

  • 1. In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167).
    Munshi A; Jalali R; Budrukar A
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):632; author reply 632-3. PubMed ID: 16690446
    [No Abstract]   [Full Text] [Related]  

  • 2. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery: in regards to Toledano et al. (Int J Radiat Oncol Biol Phys 2006;65:324-332).
    Munshi A; Jalali R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):314; author reply 314-5. PubMed ID: 16904531
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant chemotherapy in premenopausal women].
    Raabe NK
    Tidsskr Nor Laegeforen; 1991 Sep; 111(23):2857-8. PubMed ID: 1948886
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
    Ejlertsen B; Mouridsen HT; Jensen MB
    Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In response to Dr. Formenti et al. (Int J Radiat Oncol Biol Phys 2005, 63:1275-1276).
    Kao J; Conzen S; Fleming G; Recant W; Heimann R
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):658. PubMed ID: 16414377
    [No Abstract]   [Full Text] [Related]  

  • 6. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 7. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
    Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
    Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostication of hematotoxicity for radio- and chemotherapy in patients with breast cancer].
    Ivanov SD; Iamshanov VA; Korytova LI; Khazova TV; Arzumanov AS
    Vopr Onkol; 2003; 49(5):601-7. PubMed ID: 14682132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 10. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
    Sack H
    Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268
    [No Abstract]   [Full Text] [Related]  

  • 11. In regard to Kao et al.: concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials (Int J Radiat Oncol Biol Phys 2005;61:1045-1053).
    Formenti SC
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1275-6. PubMed ID: 16253785
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose density in breast cancer: a simple message?
    Lin NU; Gelman R; Winer EP
    J Natl Cancer Inst; 2005 Dec; 97(23):1712-4. PubMed ID: 16333021
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
    Dhot PS; Sharma MC; Kumar L; Saxena R
    J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
    [No Abstract]   [Full Text] [Related]  

  • 14. In regard to Dr. Ortholan et al. (Int J Radiat Oncol Biol Phys 2005;61:154-162).
    de Dios NR; Lopez MA; Latiesas XS; Arnalot PF
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):616; author reply 616. PubMed ID: 15890612
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to "benefit of radiation boost after whole-breast radiotherapy" (Int J Radiat Oncol Biol Phys 2009;75:1029-1034).
    Voogd AC; van der Sangen MJ
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):316; author reply 316. PubMed ID: 20394861
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential risk of a common hereditary thrombophilia and adjuvant chemotherapy for low-stage breast cancer.
    Ely SF
    J Clin Oncol; 2005 Jun; 23(18):4242-3. PubMed ID: 15961781
    [No Abstract]   [Full Text] [Related]  

  • 17. In regard to Allen et al.: Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645).
    Rodrigues GB; Roa WH
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):959. PubMed ID: 17544006
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial.
    Veyret C; Levy C; Chollet P; Merrouche Y; Roche H; Kerbrat P; Fumoleau P; Fargeot P; Clavere P; Chevallier B
    Cancer; 2006 Dec; 107(11):2535-44. PubMed ID: 17054108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.